| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/24/2008 | WO2008048322A1 Mouse models to study cachexia |
| 04/24/2008 | WO2008048310A2 Bimolecular constructs |
| 04/24/2008 | WO2008048306A2 Influenza a virus vaccines and inhibitors |
| 04/24/2008 | WO2008048269A2 Microarray for pathogen identification |
| 04/24/2008 | WO2008048230A2 Methods of identifying biological targets and instrumentation to identify biological targets |
| 04/24/2008 | WO2008048216A2 Electrocatalytic detection of carbon nanotubes |
| 04/24/2008 | WO2008048193A2 Breast tumour grading |
| 04/24/2008 | WO2008047947A1 Method for determining effect of cisplatin administration and kit for determining effect of cisplatin administration |
| 04/24/2008 | WO2008047824A1 Method for determining presence or absence diabetes |
| 04/24/2008 | WO2008047802A1 D-serine dehydratase and use thereof |
| 04/24/2008 | WO2008047723A1 Diagnosis and treatment of cancer using anti-ereg antibody |
| 04/24/2008 | WO2008047655A1 Urea derivative for use in quantification of hydrogen peroxide |
| 04/24/2008 | WO2008047272A2 Device for amplification and detection of nucleic acids |
| 04/24/2008 | WO2008047234A1 A molecule for providing a standard for the quantitative analysis of the methylation status of a nucleic acid |
| 04/24/2008 | WO2008047128A2 Materials and methods for determining susceptibility to cancer |
| 04/24/2008 | WO2008047095A1 Method |
| 04/24/2008 | WO2008046964A2 Novel useful inhibitors |
| 04/24/2008 | WO2008046923A2 Methodology for analysis of sequence variations within the hcv ns3/4a genomic region |
| 04/24/2008 | WO2008046922A2 Methodology for anaysis of sequence variations within the hcv ns5b genomic region |
| 04/24/2008 | WO2008046911A2 Novel human micrornas associated with cancer |
| 04/24/2008 | WO2008046664A1 Method and device for the selective isolation of serotypes of shiga toxin producing e. coli |
| 04/24/2008 | WO2008046645A2 A new method for qualitative and quantitative detection of short nucleic acid sequences of about 8-50 nucleotides in length |
| 04/24/2008 | WO2008046543A1 Cell protective genes |
| 04/24/2008 | WO2008046528A1 Npr3 as a biomarker, therapeutic and diagnostic target |
| 04/24/2008 | WO2008046517A1 Ctgf as a biomarker, therapeutic and diagnostic target |
| 04/24/2008 | WO2008046511A1 Crtac as a biomarker, therapeutic and diagnostic target |
| 04/24/2008 | WO2008046510A1 Fn1 as a biomarker, therapeutic and diagnostic target |
| 04/24/2008 | WO2008046509A1 Ltbp2 as a biomarker, therapeutic and diagnostic target |
| 04/24/2008 | WO2008046508A1 Tgfb2 as a biomarker, therapeutic and diagnostic target |
| 04/24/2008 | WO2008046213A1 Measuring multiple analytes over a broad range of concentrations using optical diffraction |
| 04/24/2008 | WO2008046189A1 Proteins involved in after-cooking darkening in potatoes |
| 04/24/2008 | WO2008046182A1 Stroma derived predictor of breast cancer |
| 04/24/2008 | WO2008029085A3 Polymerase |
| 04/24/2008 | WO2008028156A3 Method for producing nucleic acid probes |
| 04/24/2008 | WO2008027558A3 Iterative nucleic acid assembly using activation of vector-encoded traits |
| 04/24/2008 | WO2008026927A3 Process for displaying t- and b-cell receptor repertoires |
| 04/24/2008 | WO2008025564A3 Methods for detecting protein-peptide interactions |
| 04/24/2008 | WO2008025170B1 Selective glycosidase inhibitors and uses thereof |
| 04/24/2008 | WO2008012534A3 Retinoids and small molecules as nrf2 antagonists for use in the treatment of diseases associated with abnormal cell proliferation |
| 04/24/2008 | WO2008009857A3 Modulators of udp-glucose ceramide glucosyltransferase in the treatment of acne or of hyperkeratinization |
| 04/24/2008 | WO2008008983A3 Methods and nucleic acids for analyses of cellular proliferative disorders |
| 04/24/2008 | WO2008007959A3 Methods of detecting root knot nematodes |
| 04/24/2008 | WO2008002882A3 Device and method for extraction and analysis of nucleic acids from biological samples |
| 04/24/2008 | WO2007149935A3 Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activator |
| 04/24/2008 | WO2007146334A3 Co-culture lymphoid tissue equivalent (lte) for an artificial immune system (ais) |
| 04/24/2008 | WO2007140352A3 Plasma membrane and secreted cancer biomarkers |
| 04/24/2008 | WO2007123579B1 Translational dysfunction based therapeutics |
| 04/24/2008 | WO2007118704A3 Methods and nucleic acids for the detection of colorectal cell proliferative disorders |
| 04/24/2008 | WO2007109067A3 Non-random aptamer libraries and methods for making |
| 04/24/2008 | WO2007081768A3 Use of he4 and other biochemical markers for assessment of ovarian cancers |
| 04/24/2008 | WO2007081767A3 Use of he4 and other biochemical markers for assessment of endometrial and uterine cancers |
| 04/24/2008 | WO2007078833A3 Reusable pcr amplification system and method |
| 04/24/2008 | US20080098495 Disease resistant, enhanced shelf life, taste improved, stress tolerant eruca sativa |
| 04/24/2008 | US20080098493 Carrots having increased lycopene content |
| 04/24/2008 | US20080097737 Apparatus and method for coding genetic information |
| 04/24/2008 | US20080097607 Pigmentable epidermis equivalent prepared from matrix cells and methods for the production thereof |
| 04/24/2008 | US20080097115 An oligonucleotide having a free 3' or 5'-amino group silylated to DNA intermediate; immobilizating silylated oligonucleotides or proteins |
| 04/24/2008 | US20080097090 Functional and hyperfunctional siRNA directed against Bcl-2 |
| 04/24/2008 | US20080097083 Granulocyte cell stimulating factor (G-CSF), erythropoietin, interferon, and growth hormone |
| 04/24/2008 | US20080097082 Nucleotide sequences coding recombinant protein for use in prevention and treatment of hyperphosphatemia |
| 04/24/2008 | US20080096981 modulating activities associated with the IL-9 pathway for the treatment of atopic allergies like asthma; autoimmune diseases; new genes tightly expressed in association with an inflammatory response in the airways mediated by type 2 helper T-cells (TH). These genes have been designated TH2AF1 |
| 04/24/2008 | US20080096980 which cause various pathologies including Parkinson's, Huntington's, and Alzheimer's Diseases; agent that induces a survival response by the cell; induces sequestration of toxic protein in an inclusion body; |
| 04/24/2008 | US20080096892 C-Kit Modulators And Methods Of Use |
| 04/24/2008 | US20080096838 Guanosine rich oligonucleotides and methods of inducing apoptosis in tumor cells |
| 04/24/2008 | US20080096833 Diagnostic drugs and kits; coded for human proto-oncogene Pim-3, an antibody specific thereto; short interence RNA; genetic engineering |
| 04/24/2008 | US20080096769 Phage displayed trp cage ligands |
| 04/24/2008 | US20080096768 Epigenetic sequences for esophageal adenocarcinoma |
| 04/24/2008 | US20080096250 Expression vector comprising nucleotide sequences coding inflammatory response polypeptide for use in treatment and prevention of inflammation |
| 04/24/2008 | US20080096241 Method of detecting drug resistant microorganisms by surface plasmon resonance system |
| 04/24/2008 | US20080096240 Novel prostamide receptor antagonists |
| 04/24/2008 | US20080096239 Orphan Nuclear Receptor |
| 04/24/2008 | US20080096238 Using gamma labeled substrates as reporter tool in identifying modulators of transferase activity; identifying modulators for prevention and treatment of hypertension, respiratory, cell proliferative and cardiovascular disorders |
| 04/24/2008 | US20080096223 Using von willebrand factor (vWF) conformation as a evaluative/predictive tool in identifying blood disorders |
| 04/24/2008 | US20080096221 Method Of Detecting Platelet Thrombosis Or Organ Failure |
| 04/24/2008 | US20080096218 Using blot analysis to identify N-ethylmaleimide-sensitive fusion protein (NSF) in corn; propagating plants resistannt to pigment synthesis-inhibiting class of herbicides |
| 04/24/2008 | US20080096217 Methods for evaluating pathologic conditions using extracellular RNA |
| 04/24/2008 | US20080096216 Using immobillized probes to detect preferential gene sequences; high throughput assay; microfluidics |
| 04/24/2008 | US20080096215 Using sulfatase gene expression as evaluative tool in detection, prevention and treatment of cell proliferative disorders |
| 04/24/2008 | US20080096214 Keeping a solid support material in suspension within a fluid medium; moving the container in a circular path about a first axis of rotation; simultaneously rotating the container about a second axis of rotation that is spaced from and generally parallel to the first axis of rotation |
| 04/24/2008 | US20080096213 Identifying unmethylated DNA sequence using bisulfite treatment; diagnosing cell proliferative disorders |
| 04/24/2008 | US20080096212 Using allelic variation in epidermal growth factor receptor (EGFR) gene as evaluative tool in predicting positive response to antitumor treatments/therapies |
| 04/24/2008 | US20080096211 Expression vector comprising nucleotide sequences coding stability gene expression or protein secretion/folding (SES) proteins for enhancing production of functional heterologous polypeptides |
| 04/24/2008 | US20080096210 Cancer suppressing agent |
| 04/24/2008 | US20080096209 Using sequence information from acquired immunodeficiency virus envelope gene V3 region as evaluative and predictive tool in determining most effective antiviral treatments for AIDS patients |
| 04/24/2008 | US20080096208 Biomarkers for assessing response to c-met treatment |
| 04/24/2008 | US20080096207 Leptin and Growth Hormone Receptor Gene Markers Associated with Rearing, Carcass Traits and Productive Life in Cattle |
| 04/24/2008 | US20080096206 Polynucleotide Sequencing Using a Helicase |
| 04/24/2008 | US20080096205 Diagnostic methods and kits for colorectal cancer |
| 04/24/2008 | US20080096204 Method and apparatus for determining cancer metastasis |
| 04/24/2008 | US20080096203 Method and device for detecting quinolone-resistant escherichia coli |
| 04/24/2008 | US20080096202 Transgenic mammal comprising pancreatic ER kinase gene (PERK) for identifying modulators for prevention and treatment of nervous system disorders |
| 04/24/2008 | US20080096201 Glyceraldehyde-3-phosphate dehydrogenase and Saframycin A/dna complexes; evaluation of microbiocidal and antiproliferative activity; kits |
| 04/24/2008 | US20080096200 Methods for detection of a target nucleic acid by capture using multi-subunit probes |
| 04/24/2008 | US20080096199 Method for the Carry-Over Protection In Dna Amplification Systems Targeting Methylation Analysis Achieved by a Modified Pre-Treatment of Nucleic Acids |
| 04/24/2008 | US20080096198 Primer Having Promoter Region Added Thereto |
| 04/24/2008 | US20080096197 Compounds and Methods for Assessment of Microsatellite Instability (Msi) Status |
| 04/24/2008 | US20080096196 Method for Analyzing Samples by Means of Hybridization |
| 04/24/2008 | US20080096195 Nutrient broth for propagation of gramnegative bacteria; food safety and quality control |
| 04/24/2008 | US20080096194 Using fragment identification mapping for gene expression analysis, tumor and pathogen detection |
| 04/24/2008 | US20080096193 Quantitative analysis; optical properties; kits |